معرفی
Randa Tao, MD is an Adjunct Professor in Radiation Oncology with extensive clinical and research expertise spanning lymphoma, gastrointestinal cancers, and breast cancer. Her work focuses on radiation therapy outcomes, stereotactic techniques, and psychosocial aspects of cancer care across multiple institutions.
Her educational foundation includes:
- MD from Icahn School of Medicine at Mount Sinai
- Residency at University of Texas M.D. Anderson Cancer Center
- Internship at University of Texas Health Science Center
- Research Fellowship at Howard Hughes Medical Institute-NIH
- BS from University of Michigan
Dr. Tao's research integrates clinical oncology with translational science, emphasizing radiation therapy optimization for lymphomas and hepatobiliary cancers. She pioneered investigations into mental health impacts on Hodgkin lymphoma survival and developed protocols for reirradiation in recurrent pelvic cancers. Her work on Calypso beacon-guided lung SBRT demonstrates technical innovation, while NCCN guideline contributions shape national lymphoma treatment standards.
Analysis of her 2021-2023 publications reveals dominant themes in cholangiocarcinoma management (liver transplant protocols, neoadjuvant regimens), lymphoma therapeutics (rituximab-era patterns, secondary malignancy risks), and radiation technique advancements (workflow integration, hypoxia imaging). Her research consistently bridges clinical practice with database-driven outcomes analysis.
Dr. Tao actively collaborates across major cancer centers including MD Anderson, Mount Sinai, and University of Michigan, contributing to multi-institutional trials on radiation sequencing in lung cancer and pancreatic cancer resection outcomes. Her clinical practice incorporates mental health screening as a standard component of lymphoma survivorship care.
